These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6577132)

  • 21. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bioavailability of phenytoin. Comparison of data obtained in vitro, in healthy volunteers and in epileptic patients].
    Albani F; Pazzaglia P; Procaccianti G; Riva R; Baruzzi A
    Boll Chim Farm; 1981 Dec; 120(12):715-24. PubMed ID: 7344725
    [No Abstract]   [Full Text] [Related]  

  • 23. No influence of pantoprazole on the pharmacokinetics of phenytoin.
    Middle MV; Müller FO; Schall R; Groenewoud G; Hundt HK; Huber R; Bliesath H; Steinijans VW
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S72-5. PubMed ID: 8793606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of phenytoin metabolism by other drugs used in epilepsy.
    Houghton GW; Richens A
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):210-6. PubMed ID: 240782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of food on the absorption of phenytoin.
    Kennedy MC; Wade DN
    Aust N Z J Med; 1982 Jun; 12(3):258-61. PubMed ID: 6956293
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacogenetic studies.
    Drug Metab Dispos; 1980; 8(3):187-8. PubMed ID: 6104585
    [No Abstract]   [Full Text] [Related]  

  • 27. Phenytoin disposition in smokers and nonsmokers.
    Rose JQ; Barron SA; Jusko WJ
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):547-50. PubMed ID: 730422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacokinetics of sodium valproate, carbamazepine and phenytoin. Level-dose ration and interactions.
    Levy RH; Moreland TA
    Schweiz Rundsch Med Prax; 1984 Feb; 73(6):159-63. PubMed ID: 6424205
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative bioavailability of several phenytoin preparations marketed in Austria.
    Nitsche V; Mascher H; Schütz H
    Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):104-7. PubMed ID: 6698663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the bioavailability of Polfa phenytoin tablets].
    Lazowski J; Lypka A; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1978; 12(3):251-5. PubMed ID: 683430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inheritance of phenytoin hypometabolism: a kinetic study of one family.
    Vasko MR; Bell RD; Daly DD; Pippenger CE
    Clin Pharmacol Ther; 1980 Jan; 27(1):96-103. PubMed ID: 7351122
    [No Abstract]   [Full Text] [Related]  

  • 32. Advocating single-dose phenytoin loading.
    Horton MW; Godley PJ
    Ann Emerg Med; 1988 Mar; 17(3):295-6. PubMed ID: 3345027
    [No Abstract]   [Full Text] [Related]  

  • 33. Particle size distribution affects the human bioavailability of phenytoin.
    Yakou S; Yamazaki S; Sonobe T; Sugihara M; Fukumuro K; Nagai T
    Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4400-2. PubMed ID: 3829172
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of vehicle on gastrointestinal absorption of phenytoin in rats.
    Shinkuma D; Hamaguchi T; Yamanaka Y; Mizuno N; Yata N
    Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):4981-8. PubMed ID: 3830425
    [No Abstract]   [Full Text] [Related]  

  • 35. Nonlinear assessment of phenytoin bioavailability.
    Jusko WJ; Koup JR; Alván G
    J Pharmacokinet Biopharm; 1976 Aug; 4(4):327-36. PubMed ID: 978395
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bioavailabilities of three different phenytoin powders sold in Japan].
    Suzuki H; Hirayama Y; Oka S; Koide Y; Moroka K
    No To Hattatsu; 1985 Jan; 17(1):44-9. PubMed ID: 3970779
    [No Abstract]   [Full Text] [Related]  

  • 37. The clinical pharmacokinetics of phenytoin.
    Martin E; Tozer TN; Sheiner LB; Riegelman S
    J Pharmacokinet Biopharm; 1977 Dec; 5(6):579-96. PubMed ID: 599408
    [No Abstract]   [Full Text] [Related]  

  • 38. Failure of antacids to alter the pharmacokinetics of phenytoin.
    O'Brien LS; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1978 Aug; 6(2):176-7. PubMed ID: 678394
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of dietary components on the bioavailability of phenytoin.
    Sekikawa H; Nakano M; Takada M; Arita T
    Chem Pharm Bull (Tokyo); 1980 Aug; 28(8):2443-9. PubMed ID: 7428127
    [No Abstract]   [Full Text] [Related]  

  • 40. Phenytoin: basic and clinical pharmacology.
    Jones GL; Wimbish GH; McIntosh WE
    Med Res Rev; 1983; 3(4):383-434. PubMed ID: 6358722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.